Pediatrics

FDA Expands Ustekinumab to Pediatric Plaque Psoriasis

July 31, 2020

Article

The expansion makes history for the injection biologic.

Pediatric Multisystem Inflammatory Disease and COVID-19

July 24, 2020

Article

Until more is known about long-term cardiac mechanisms behind MIS-C, providers could consider following Kawasaki disease guidelines for follow-up care

DBT an Option for PTSD Treatment Following Childhood Abuse

July 23, 2020

Article

Patients in the DBT group were less likely to drop out early and had higher rates of symptomatic remission than a comparison CPT treatment group.

AR101 Leads to Rapid Desensitization of Peanut Protein

July 22, 2020

Article

The findings provide data to help physicians, patients, and caregivers make informed, shared decisions on the management of peanut allergy.

FDA Approves New Cataplexy and Daytime Sleepiness Treatment for Narcolepsy

July 22, 2020

Article

The approval represents the second approved treatment of the conditions associated with narcolepsy patients at least 7 years old.

Better Screening Needed for Pediatric Mild Traumatic Brain Injuries

July 21, 2020

Article

Symptom provocation did not meaningfully alter the diagnostic sensitivity and specificity that is relative to more easily obtained pretests symptom ratings.

Barriers Prevent Pediatricians from Implementing Peanut Allergy Guidelines

July 15, 2020

Article

Although a majority of pediatricians are aware of the guidelines, less than one-third of survey respondents report full implementation.

FDA Issues Complete Response Letter for VP-102 for Molluscum

July 14, 2020

Article

The FDA is looking for more information regarding aspects of the chemistry, manufacturing, and controls process for the drug-device combination

Investigators Test Combination Therapies for First-Episode Psychosis in Adolescents

July 13, 2020

Article

Four out of 18 patients in antipsychotic monotherapy, 5 out of 16 individuals receiving psychological intervention, and 5 out of 17 receiving combined therapy achieved a good clinical response at 6 months.

Epicutaneous Immunotherapy Effective for Peanut Allergy in Children

July 13, 2020

Article

The results further support the overall benefit of epicutaneous immunotherapy.

x